Biofarm
236 articole · RSS
Buyers in good faith might have to give their Biofarm shares back
The state is supposed to become the main shareholder of Biofarm Bucharest again, according to a court ruling delivered at the end of last month, whereby the State Assets Resolution Authority...
Tudor Dumitru a mai cumparat Biofarm
Omul de afaceri Tudor Dumitru a achizitionat impreuna cu alte doua persoane fizice un pachet de peste 800.000 de actiuni la producatorul de medicamente Biofarm. In urma tranzactiei, Tudor Du...
Biofarm si-a majorat castigurile cu 50%
Producatorul de medicamente generice Biofarm Bucuresti si-a majorat profitul net cu aproximativ 50% in euro anul trecut comparativ cu 2004, la circa 3,2 milioane de euro (11,7 mil. lei), pot...
SIF Muntenia exits Biofarm with 46% profit
SIF Muntenia has sold its 2% stake in drug producer Biofarm Bucharest, following transactions on the market whereby it collected 4.5 million RON (over 1.2 million euros). The company bought...
SIF Muntenia a castigat 46% din Biofarm
SIF Muntenia a avut un profit de 46% de pe urma investitiei facute in 2% din actiunile Biofarm acum un an de zile. SIF Muntenia si-a vandut participatia de 2% detinuta in cadrul producatorul...
Tudor sells Biofarm to relatives
Businessman Dumitru Tudor, one of the main individual investors on the domestic capital market, sold his over 9% stake in drug producer Biofarm Bucharest through two deals worth approximatel...
Tudor a vandut Biofarm in familie
Omul de afaceri Dumitru Tudor, unul dintre principalii investitori persoane fizice de pe piata de capital, a vandut pachetul de peste 9% pe care il detinea la producatorul de medicamente Bio...
Tudor Dumitru parts with 1.5% in Biofarm
Businessman Tudor Dumitru, one of the biggest Romanian investors on the capital market has sold around 1.5% in pharmaceuticals manufacturer Biofarm Bucharest, reducing his stake from 11.18%...
Tudor a vandut 1,5% din Biofarm inainte de transferul pe Bursa
Omul de afaceri Tudor Dumitru, unul dintre cei mai mari investitori romani pe piata de capital, a vandut in ultimele doua saptamani circa 1,5% din actiunile producatorului de medicamente Bio...